Polaryx Therapeutics, Inc. (PLYX)
NASDAQ: PLYX · Real-Time Price · USD
1.800
+0.060 (3.45%)
Nov 6, 2026, 4:00 PM EST - Market closed
Polaryx Therapeutics Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Polaryx Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $7.50. The average 1-year stock price forecast is 316.67% higher than the current stock price, while the lowest is $6.00 (+233.33%) and the highest is $10 (+455.56%).
Price Target: $7.50 (+316.67%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Aug 13, 2026.
Analyst Ratings
The average analyst rating for Polaryx Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 2 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Initiates $6 | Buy | Initiates | $6 | +233.33% | Aug 13, 2026 |
| Lucid Capital | Lucid Capital | Buy Initiates $7 | Buy | Initiates | $7 | +288.89% | Jul 27, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.20
from -0.20
EPS Next Year
-0.29
from -0.20